Updated:
NutriBand Inc.
At Nutriband and our subsidiaries, our core focus is to use innovative drug delivery systems and devices to improve patient outcomes, specifically targeting...
NutriBand Inc.
At Nutriband and our subsidiaries, our core focus is to use innovative drug delivery systems and devices to improve patient outcomes, specifically targeting the Global Opioid epidemic. Fentanyl and other opioid based transdermal medications unfortunately play a role in a significant number of opioid deaths each year with no solution currently available. Working with our Clinical subsidiary 4P Therapeutics we have developed a technology called AVERSA which we believe with FDA approval will revolutionize the safety standard for these medications and save countless lives per year.
General information
Firm type
null
Year founded
—
AUM
Undisclosed
Location
Region
null
Country
null
City
null
Corporate office
null
Frequently asked questions
Is NutriBand Inc. a family office?
No. NutriBand Inc. is a publicly traded medical device company, not a family office. It does not manage third-party capital and does not disclose family office operations.
What is NutriBand's core technology?
NutriBand develops transdermal patch systems that deliver active pharmaceutical ingredients through the skin. Its lead product, the NtiPatch, is designed for pain management without oral medications or injections. The technology aims to improve patient compliance and reduce side effects.
Is NutriBand publicly traded?
Yes, NutriBand Inc. trades on the OTC Markets under the ticker symbol NTRB. The company files periodic reports with the SEC, which are publicly accessible.
Are there any major investors in NutriBand?
Public filings show that insiders and institutional investors hold shares, but no single family office or wealth manager is listed as a controlling investor. The company does not disclose a family office backer.
Does NutriBand have revenue or is it pre-revenue?
As of its most recent filings, NutriBand has limited revenue and operates as a development-stage company. It funds operations through equity offerings and does not disclose a family office-supported capital base.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: